Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 208

1.

Volumetric MRI differences in treatment-naïve vs chronically treated children with ADHD.

Semrud-Clikeman M, Pliśzka SR, Lancaster J, Liotti M.

Neurology. 2006 Sep 26;67(6):1023-7. Erratum in: Neurology. 2006 Dec 12;67(11):2091.

PMID:
17000972
2.

Volumetric MRI differences in treatment naïve and chronically treated adolescents with ADHD-combined type.

Semrud-Clikeman M, Pliszka SR, Bledsoe J, Lancaster J.

J Atten Disord. 2014 Aug;18(6):511-20. doi: 10.1177/1087054712443158. Epub 2012 May 31.

PMID:
22653807
3.

Volumetric MRI analysis comparing subjects having attention-deficit hyperactivity disorder with normal controls.

Filipek PA, Semrud-Clikeman M, Steingard RJ, Renshaw PF, Kennedy DN, Biederman J.

Neurology. 1997 Mar;48(3):589-601.

PMID:
9065532
4.

Dorsolateral prefrontal and anterior cingulate cortex volumetric abnormalities in adults with attention-deficit/hyperactivity disorder identified by magnetic resonance imaging.

Seidman LJ, Valera EM, Makris N, Monuteaux MC, Boriel DL, Kelkar K, Kennedy DN, Caviness VS, Bush G, Aleardi M, Faraone SV, Biederman J.

Biol Psychiatry. 2006 Nov 15;60(10):1071-80. Epub 2006 Jul 28.

PMID:
16876137
5.

Global and regional gray matter reductions in ADHD: a voxel-based morphometric study.

Carmona S, Vilarroya O, Bielsa A, Trèmols V, Soliva JC, Rovira M, Tomàs J, Raheb C, Gispert JD, Batlle S, Bulbena A.

Neurosci Lett. 2005 Dec 2;389(2):88-93.

PMID:
16129560
6.

ADHD and conduct disorder: an MRI study in a community sample.

Bussing R, Grudnik J, Mason D, Wasiak M, Leonard C.

World J Biol Psychiatry. 2002 Oct;3(4):216-20.

PMID:
12516313
7.
8.

Increased cerebral perfusion in adult attention deficit hyperactivity disorder is normalised by stimulant treatment: a non-invasive MRI pilot study.

O'Gorman RL, Mehta MA, Asherson P, Zelaya FO, Brookes KJ, Toone BK, Alsop DC, Williams SC.

Neuroimage. 2008 Aug 1;42(1):36-41. doi: 10.1016/j.neuroimage.2008.04.169. Epub 2008 Apr 20.

PMID:
18511306
9.

Executive functioning in children with attention-deficit/hyperactivity disorder: combined type with and without a stimulant medication history.

Semrud-Clikeman M, Pliszka S, Liotti M.

Neuropsychology. 2008 May;22(3):329-40. doi: 10.1037/0894-4105.22.3.329.

PMID:
18444711
10.

Longitudinal mapping of cortical thickness and clinical outcome in children and adolescents with attention-deficit/hyperactivity disorder.

Shaw P, Lerch J, Greenstein D, Sharp W, Clasen L, Evans A, Giedd J, Castellanos FX, Rapoport J.

Arch Gen Psychiatry. 2006 May;63(5):540-9.

PMID:
16651511
11.

Functional MRI in attention-deficit hyperactivity disorder: evidence for hypofrontality.

Zang YF, Jin Z, Weng XC, Zhang L, Zeng YW, Yang L, Wang YF, Seidman LJ, Faraone SV.

Brain Dev. 2005 Dec;27(8):544-50.

PMID:
15876503
12.

Effects of stimulant medications on children with attention-deficit/hyperactivity disorder and excessive beta activity in their EEG.

Clarke AR, Barry RJ, McCarthy R, Selikowitz M, Clarke DC, Croft RJ.

Clin Neurophysiol. 2003 Sep;114(9):1729-37.

PMID:
12948803
13.

Structural development of the basal ganglia in attention deficit hyperactivity disorder: a diffusion tensor imaging study.

Silk TJ, Vance A, Rinehart N, Bradshaw JL, Cunnington R.

Psychiatry Res. 2009 Jun 30;172(3):220-5. doi: 10.1016/j.pscychresns.2008.07.003. Epub 2009 Apr 24.

PMID:
19398307
14.

Asymmetry of basal ganglia in children with attention deficit hyperactivity disorder.

Uhlíkova P, Paclt I, Vaneckova M, Morcinek T, Seidel Z, Krasensky J, Danes J.

Neuro Endocrinol Lett. 2007 Oct;28(5):604-9.

PMID:
17994006
15.

Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder.

Biederman J, Seidman LJ, Petty CR, Fried R, Doyle AE, Cohen DR, Kenealy DC, Faraone SV.

J Clin Psychiatry. 2008 Jul;69(7):1150-6.

16.

[Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)].

Emond V, Joyal C, Poissant H.

Encephale. 2009 Apr;35(2):107-14. doi: 10.1016/j.encep.2008.01.005. Epub 2008 Jul 7. Review. French.

PMID:
19393378
17.

Towards further understanding of the co-morbidity between attention deficit hyperactivity disorder and bipolar disorder: a MRI study of brain volumes.

Biederman J, Makris N, Valera EM, Monuteaux MC, Goldstein JM, Buka S, Boriel DL, Bandyopadhyay S, Kennedy DN, Caviness VS, Bush G, Aleardi M, Hammerness P, Faraone SV, Seidman LJ.

Psychol Med. 2008 Jul;38(7):1045-56. Epub 2007 Oct 15.

PMID:
17935640
18.

Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder.

Castellanos FX, Giedd JN, Marsh WL, Hamburger SD, Vaituzis AC, Dickstein DP, Sarfatti SE, Vauss YC, Snell JW, Lange N, Kaysen D, Krain AL, Ritchie GF, Rajapakse JC, Rapoport JL.

Arch Gen Psychiatry. 1996 Jul;53(7):607-16.

PMID:
8660127
19.

Anterior cingulate cortex gray matter abnormalities in adults with attention deficit hyperactivity disorder: a voxel-based morphometry study.

Amico F, Stauber J, Koutsouleris N, Frodl T.

Psychiatry Res. 2011 Jan 30;191(1):31-5. doi: 10.1016/j.pscychresns.2010.08.011. Epub 2010 Dec 3.

PMID:
21129938
20.

No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.

Walitza S, Kämpf K, Artamonov N, Romanos M, Gnana Oli R, Wirth S, Warnke A, Gerlach M, Stopper H.

Toxicol Lett. 2009 Jan 10;184(1):38-43. doi: 10.1016/j.toxlet.2008.10.011. Epub 2008 Oct 28.

PMID:
19015014

Supplemental Content

Support Center